Does METS-VF outperform traditional adiposity indices in predicting overactive bladder risk in adults in the USA?
METS-VF is a superior predictor of overactive bladder risk compared to traditional adiposity indices in US adults, offering potential value for clinical risk assessment.
The METS-VF, an innovative composite indicator of visceral adiposity and metabolic dysfunction, serves as a robust and reliable predictor of OAB risk among adults in the USA. Its enhanced predictive capacity relative to traditional adiposity metrics highlights its potential application in clinical risk assessment and public health strategies aimed at mitigating visceral obesity-related urological conditions.
Cai et al. (Thu,) studied this question.